Background Glaucoma is a heterogeneous group of conditions involving progressive
damage to the optic nerve, deterioration of retinal ganglion cells, and ultimately visual field …

Glaucoma is an optic neuropathy, specifically a neurodegenerative disease characterized
by loss of retinal ganglion cells (RGCs) and their axons. The pathogenesis of RGC loss in …

Glaucoma, a leading cause of irreversible blindness worldwide, is an optic neuropathy
characterized by the progressive death of retinal ganglion cells (RGCs). Elevated intraocular …

Glaucoma is considered to be one of the biggest health problems in the world. It is the main
cause of preventable blindness due to its asymptomatic nature in the early stages on the …

Nanostructured lipid carriers (NLCs) loaded with palmitoylethanolamide (PEA) were
formulated with the aim to enhance ocular bioavailability of PEA, particularly to the back of …

Current treatment strategies for glaucoma are limited to halting disease progression and do
not restore lost visual function. Intraocular pressure is the main risk factor for glaucoma, and …

Palmitoylethanolamide (PEA) is a natural fatty acid amide found in a variety of foods, which
was initially identified in egg yolk. Micro PEA of defined particle size (0.5–10 μm) was …

Inflammation as well as glutamate excitotoxicity have been proposed to participate in the
propagation of autism. Palmitoylethanolamide (PEA) is an endocannabinoid proven to …

Title: A Pharmacokinetic study showing the increased absorption of palmitoylethanolamide
using LipiSperse®. Background: Palmitoylethanolamide (PEA) is a naturally occurring …

The observation that marijuana reduces intraocular pressure was made by Hepler and
Frank in the 1970s. Since then, there has been a significant body of work investigating …